BOARD OF DIRECTORS

Klas Arildsson
Chairman of the Board since 2020

Klas Arildsson has extensive experience in global operations and life science. Most recently he served as VP Operations Getinge Infection AB and previously led business areas for two other life science companies as Senior VP of Global Supply Chain  at Gambro Renal Products and VP Supply Chain Manufacturing at Baxter Inc. Additional past roles include VP of Operations at Cardo Door and Quality Manager and Plant Manager at Ericsson Telecom. Previous board assignments include Director at Life Assays AB and Director at Lund Nyföretagarcentrum.

  • Other appointments: Board member of Redsense Medical AB, Board member of Gambro Lundia AB, and  member of Lund University’s Business Council.
  • Education: Mr. Arildsson completed the KTH Royal Institute of Technology Executive Management Program.
  • Born: 1960
  • Holdings: 10 000 shares, 300 000 options issued by Dignitana and 300 000 options issued by Adma Förvaltnings AB
  • Independence: Independent in relation to the company, the company’s senior executives and major shareholders of the company.

William Cronin
Chief Executive Officer
Board Member since 2015
William Cronin began his career in finance, starting with Shearson Lehman Brothers in New York in 1987 and then moving to Dallas in 1992 to work with Capital Institutional Services as their Head of International Sales and Trading. After leaving CIS in 1999, Mr. Cronin became President of Direct Trading Institutional, an early pioneer in high speed electronic trading, which was ultimately sold to Knight Capital Group (KCG: NYSE).

Mr. Cronin became involved with scalp cooling after his wife’s diagnosis with breast cancer in 2011. After her success with scalp cooling, together they founded Chemo Cold Caps, LLC, one of the largest US-based providers of manual scalp cooling solutions to patients. Mr. Cronin began working with Dignitana in 2014 as the company’s clinical trial was being completed, becoming COO of the US subsidiary after FDA clearance in 2015.  He was appointed CEO of Dignitana Inc. in 2016 and of AB in November 2017.

  • Other appointments: Chairman of the Board of C3 Device Partners
  • Education: Mr. Cronin holds BA from Muhlenberg College in Pennsylvania and has a Master’s in Business Administration in Finance from the University of Texas, Dallas.
  • Born: 1965
  • Holdings: 4 245 739 through shareholding in C3 Device Partners as of 2020-06-30
  • Independence: Dependent in relation to the company, the company’s senior executives and major shareholders of the company.

richard DiIorio
Board Member since 2020

Richard DiIorio

 

Richard DiIorio is President & CEO of InfuSystem Holdings (INFU), a leading U.S. healthcare company providing medical devices and services to hospitals, home infusion providers, oncology practices and patients. He has a strong track record of accomplishment with more than 20 years of medical sales experience, expertise in product launch, and industry knowledge focused on driving growth in the oncology market. Previously he held various sales and sales leadership roles at Stryker Medical, Novartis Pharmaceuticals, and Thermo Scientific.

  • Other appointments:  Director, InfuSystem Holdings
  • Education: Mr. DiIorio earned a Bachelor of Science degree in Biology from Boston College.
  • Born: 1974
  • Holdings: none
  • Independence: Independent in relation to the company, the company’s senior executives and major shareholders of the company.

Ingrid Atteryd Heiman

Board Member since 2018
Ingrid Atteryd Heiman has worked with companies spanning the women’s health, food, pharmaceutical, biotech, life science, and financial services industries. Most recently, from 2014 to 2015 she served as Acting Chief Executive Officer of Ellen AB (Publ), a biotech company offering patented probiotic products treated to improve women’s health where she also has served as Chairman of the Board. Ms. Atteryd Heiman’s leadership experience includes services as Chief Executive Officer for three successful companies, several board chairman positions, and board member positions, primarily with those listed on OMX First North Growth and Spotlight Stock Market which demands effective communication with the market and shareholders. She has a proven ability to successfully strategize business development and drive profit and growth. Through her years as a management consultant she has been involved in change management, efficiency optimization, strategy development, mergers, and acquisitions.

  • Other appointments: Chairman of the Board of Doxa AB (Publ), Director of Redwood Pharma AB (Publ), Director of Herantis Pharma Plc (Publ), Director of Parkinson Research Foundation.
  • Education: Ms. Atteryd Heiman attended Lund University, where she obtained a BA in Finance and B2B marketing, and Uppsala University where she obtained an MBA in International Business. She has also completed the StyrelseAkademien board member training.
  • Born: 1958
  • Holdings: 10 000 as of 2020-06-30
  • Independence: Independent in relation to the company, the company’s senior executives and major shareholders of the company.

Pontus Kristiansson

Board Member since 2019

Pontus Kristiansson is a strategy consultant with Altaverita AB. Pontus has more than 20 years’ experience as founder, CEO and Board executive of several startup and growth businesses. He started his career with the consumer goods marketing company Procter & Gamble and thereafter as a strategy consultant with McKinsey & Co before launching his first technology company 1999. He is also a climate impact investor and Chairman of the investment firm Realinvest AB. He has extensive experience from acting in leading positions and of Board work within a number of companies, e.g. as CEO and Board member of Kollektiva Innovation Studios AB, Vice President of Marketing at Rich Relevance Inc., Board member of IKANO Försäkring AB, CEO and Board member of Avail Intelligence AB, Business Development Consultant at Maersk Data Sverige AB and CEO of Absalon Group AB.

  • Other appointments: Chairman of the Board of Realinvest AB.
  • Education: Mr Kristiansson holds a MSc in Engineering from Lund University LTH.
  • Born 1971
  • Holdings: 16 800 as of 2020-06-30
  • Independence: Independent in relation to the company, the company’s senior executives and major shareholders of the company.

Christian Lindgren

Board Member since 2020

Christian Lindgren has extensive experience in the investment sector and serves as CEO of Adma Förvaltnings AB. He previously served as CFO and administrative head of companies such as HSB Malmö, Sparbanken Syd, Meaning Green and CFO and later CEO of Active Capital AB.

  • Other appointments: CEO at Adma Förvaltnings AB and member of board in Doxa AB, Kollektiva Innovations Studio AB, Safeture AB and Grosshold AB.
  • Education: Mr. Lindgren attended School of Business, Economics and Law at University of Gothenburg.
  • Born: 1974
  • Holdings: none
  • Independence: Independent of executive management but not independent of major shareholder.

Ljubo Mrnjavac

Board Member since 2020

Ljubo Mrnjavac has demonstrated success in the investment management industry and is Head of Investment at Adma Förvaltnings AB. He has broad entrepreneurial experience and is founder of Pölsemannen and co-founder and CEO of venture capital company Rosengård Invest. Previous roles include CEO of Tulip Food Concepts and founder and CEO of Scandinavian Cap.

  • Other appointments: Board member of Lund University Food Science, operates the football club FC Rosengård
  • Education: Mr. Mrnjavac attended IHM Business School and received an MBA from Lund University.
  • Born: 1963
  • Holdings: none
  • Independence: Independent of executive management but not independent of major shareholder.

SENIOR EXECUTIVES

WILLIAM CRONIN

Chief Executive Officer since 2017 (at Dignitana since 2014)
Born 1965

William Cronin began his career in finance, starting with Shearson Lehman Brothers in New York in 1987 and then moving to Dallas in 1992 to work with Capital Institutional Services as their Head of International Sales and Trading. After leaving CIS in 1999, Mr. Cronin became President of Direct Trading Institutional, an early pioneer in high speed electronic trading, which was ultimately sold to Knight Capital Group (KCG: NYSE).

Mr. Cronin became involved with scalp cooling after his wife’s diagnosis with breast cancer in 2011. After her success with scalp cooling, together they founded Chemo Cold Caps, LLC, one of the largest US-based providers of manual scalp cooling solutions to patients. Mr. Cronin began working with Dignitana in 2014 as the company’s clinical trial was being completed, becoming COO of the US subsidiary after FDA clearance in 2015. He was appointed CEO of Dignitana Inc. in 2016 and of AB in November 2017.

Other appointments: Chairman of the Board of C3 Device Partners

Education: Mr. Cronin holds a BA from Muhlenberg College in Pennsylvania and has a Master’s in Business Administration in Finance from the University of Texas, Dallas.

Holdings: 4 245 739 through shareholding in C3 Device Partners as of 2020-03-31

Independence: Dependent in relation to the company, the company’s senior executives and major shareholders of the company.

JAMES MCKINNEY

President and Chief Operating Officer since 2018 (at Dignitana since 2016)
Born 1953

James McKinney brings extensive experience and a proven track record in leadership and operations including physician relations and partnership, program design and implementation, financial performance and system integration.

Jim joined Dignitana in June 2016 as a healthcare consultant. He was appointed COO in November 2016, and President in March 2018. His prior leadership roles include CEO of Clinical Partners and HB Anesthesia Groups and Division President of Iasis, President and COO of Leland Medical, and President and CEO of Brim Healthcare. He also serves as a healthcare consultant to Catholic Healthcare Systems and Catholic Relief Services.

Education: Mr. McKinney holds a BSc and a MBA from Columbia State University

JONAS SOHLMAN

Chief Financial Officer since 2020
Born 1965

Jonas Sohlman has more than 25 years’ experience working in the financial sector where he has been engaged in finance and tax matters from an international perspective.

Mr. Sohlman has worked as a CFO for a smaller, listed start-up company and has extensive experience in asset management and financial functions within larger Swedish industrial companies. He also has experience in general management issues, funding, restructuring of balance sheets and legal structures, implementation of hybrid instruments, as well as divestment’s and acquisitions.

Other appointments: Board member of Flyinge AB and Ridskolan Strömsholm AB. Also serves as teacher at Swedish Academy of Board Directors.

Education: Mr. Sohlman holds a BA from Stockholm University – Economics and Business Administration

MELISSA BOURESTOM

Vice President Marketing and Investor Relations since 2016
Born 1967

Ms. Bourestom brings to Dignitana more than 25 years of experience in marketing, communications, event planning and sales. Her expertise is in building strong customer relationships via traditional and digital marketing strategies. Prior to joining Dignitana, she served as Executive Director of the American Advertising Federation Dallas and directed marketing and sales for myFootpath, an education technology start-up in Chicago. She previously worked in sales for Brinker International, in clinical services at Children’s Medical Center Dallas, and in account management at Spier Advertising NY.

Education: Ms. Bourestom holds a BA from Vanderbilt University – International Communications.

DARREN HENDERSON

Vice President Quality and Regulatory Affairs since 2017
Born 1967

Darren has over twenty-eight years’ experience working with class I, II, and III medical device companies such as Johnson and Johnson, GlaxoSmithKline and Thermo Fisher Scientific. His past work includes time in research and development and managing departments including production, quality assurance and quality control, sales, regulatory affairs, purchasing and warehousing. For the past several years he has worked as a consultant helping global medical device companies meet the demanding regulations of various governmental bodies.

Education: Mr. Henderson holds a BA Degree Management, Texas AM University Commerce and a A.A.S. Degree, General Science, Mountain View College. He also holds a Regulatory Affairs Certification (RAC) and is a member of the Regulatory Affairs Professions Society (RAPS.)

BRYAN NICHOLSON

Vice President U.S. Sales since 2020
Born 1979

Mr. Nicholson brings 18 years of experience in the medtech industry with a focus on building sales infrastructure and operations in the United States. Specifically, he brings a vast amount of experience in hypothermia and targeted temperature management systems. Most recently he served as Global Vice President of Sales and Marketing for BrainCool, Inc. Prior to joining Dignitana, he also held positions with LKC Technology, Cryothermic Systems, Inc., CR Bard, Sanofi and Bayer Healthcare.

Education: Mr. Nicholson holds a BS in Marketing from West Chester University and an MBA from Penn State University.

Holdings: 10 000 as of 2020-03-31

CAMERON O’MARA

Vice President Global Sales since 2019
Born 1979

Mr. O’Mara brings extensive experience originating new market opportunities for innovative products and services globally. After beginning his career at Arena Capital Partners LP, a middle market private equity firm in New York City, Cameron co-founded several global clean drinking water companies. As part of his duties he spearheaded project development efforts across over twenty emerging markets; establishing partnerships and formal dialogue with local influencers and government officials throughout. Cameron was invited to discuss creative solutions to improve fresh drinking water supplies and associated health standards with Heads of State and senior government ministers across three different continents.

Other appointments: Director, Hydro Nova LTD

Education: Mr. O’Mara holds a BA in Psychology from Harvard College.

Please note that the content of this website is not intended as professional medical or healthcare advice and should not be construed as a substitute for professional healthcare advice, or services from a qualified professional healthcare provider familiar with your unique situation. This content is intended solely as a general product and corporate information.

OPERATIONS
Dignitana
10925 Estate Lane, Suite 185
Dallas, TX 75238
+1 469-917-5555

HEADQUARTERS
Dignitana AB
Traktorgränden 3
226 60 Lund, Sweden
+46 46 16 30 90

HEADQUARTERS
Dignitana S.r.l.
Corso di Porta Nuova, 46
20121 Milan, Italy